BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1233 related articles for article (PubMed ID: 16534423)

  • 21. [Epidemiology of chronic inflammatory bowel disease in Gijón, Asturias].
    Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; Navascues CA; Garcia López R; Suárez González A; Diaz Alvarez G; Palacios Galán A; Altadill arregui A; Vizoso F; González Bernal A; Martínez A
    Gastroenterol Hepatol; 2001 May; 24(5):228-35. PubMed ID: 11412590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory bowel disease in Iran: a review of 457 cases.
    Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006.
    Lakatos L; Kiss LS; David G; Pandur T; Erdelyi Z; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Lakatos PL
    Inflamm Bowel Dis; 2011 Dec; 17(12):2558-65. PubMed ID: 22072315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional status of children with inflammatory bowel disease in Saudi Arabia.
    El Mouzan MI; Al Edreesi MH; Al-Hussaini AA; Saadah OI; Al Qourain AA; Al Mofarreh MA; Al Saleem KA
    World J Gastroenterol; 2016 Feb; 22(5):1854-8. PubMed ID: 26855544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data.
    Nerich V; Monnet E; Etienne A; Louafi S; Ramée C; Rican S; Weill A; Vallier N; Vanbockstael V; Auleley GR; Allemand H; Carbonnel F
    Inflamm Bowel Dis; 2006 Mar; 12(3):218-26. PubMed ID: 16534424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands.
    de Groof EJ; Rossen NG; van Rhijn BD; Karregat EP; Boonstra K; Hageman I; Bennebroek Evertsz F; Kingma PJ; Naber AH; van den Brande JH; Mallant-Hent RC; Mundt MW; D'Haens GR; Ponsioen CY
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1065-72. PubMed ID: 27281507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.
    Bernstein CN; Nabalamba A
    Am J Gastroenterol; 2006 Jan; 101(1):110-8. PubMed ID: 16405542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population.
    Halme L; Turunen U; Heliö T; Paavola P; Walle T; Miettinen A; Järvinen H; Kontula K; Färkkilä M
    Scand J Gastroenterol; 2002 Jun; 37(6):692-8. PubMed ID: 12126248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.
    Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS
    Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom.
    Tsironi E; Feakins RM; Probert CS; Rampton DS; Phil D
    Am J Gastroenterol; 2004 Sep; 99(9):1749-55. PubMed ID: 15330914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.
    Herrinton LJ; Liu L; Lewis JD; Griffin PM; Allison J
    Am J Gastroenterol; 2008 Aug; 103(8):1998-2006. PubMed ID: 18796097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary thyroid cancer and inflammatory bowel disease: is there a relationship?
    Sonu IS; Blonski W; Lin MV; Lewis J; Aberra F; Lichtenstein GR
    World J Gastroenterol; 2013 Feb; 19(7):1079-84. PubMed ID: 23467027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory bowel disease in Scottish children.
    Bland RM; Evans TJ; Raine P; Weaver LT
    Health Bull (Edinb); 1999 Nov; 57(6):365-73. PubMed ID: 12811868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
    Jess T; Riis L; Vind I; Winther KV; Borg S; Binder V; Langholz E; Thomsen OØ; Munkholm P
    Inflamm Bowel Dis; 2007 Apr; 13(4):481-9. PubMed ID: 17206705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience.
    Kim BJ; Song SM; Kim KM; Lee YJ; Rhee KW; Jang JY; Park SJ; Yoon CH
    Dig Dis Sci; 2010 Jul; 55(7):1989-95. PubMed ID: 19763825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.
    Massuger W; Moore GTC; Andrews JM; Kilkenny MF; Reyneke M; Knowles S; Purcell L; Alex G; Buckton S; Page AT; Stocks N; Cameron D; Manglaviti F; Pavli P
    Intern Med J; 2019 Jul; 49(7):859-866. PubMed ID: 30525299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.